{"id":324801,"date":"2024-12-05T13:11:18","date_gmt":"2024-12-05T12:11:18","guid":{"rendered":"https:\/\/ga-p.com\/prensa\/ga_p-asesora-a-ampersand-capital-partners-en-una-inversion-en-vivebiotech\/"},"modified":"2025-01-22T18:30:09","modified_gmt":"2025-01-22T17:30:09","slug":"ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech","status":"publish","type":"noticia","link":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/","title":{"rendered":"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech"},"content":{"rendered":"
\n
\n
\n
\n
\n\n

G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.<\/h4>\n\n\n\n

Ampersand’s entry will enable the expansion of the Gipuzkoan biotech company’s lentiviral vector manufacturing capacity and support the execution of its portfolio of pioneering client projects developing innovative cell and gene therapies in vivo and ex vivo.<\/p>\n\n\n\n

The team has been formed by David Gonz\u00e1lez, Diana Linage, Laura Roda and Nicolas Otero, partner, counsel and associates of the Corporate team; Mariana D\u00edaz-Moro and Carla Fandi\u00f1o, partner and associate of the Tax team; Irene Fern\u00e1ndez-Puyol and Marta Rey, partner and associate of the Public team; Lourdes Escassi, Carmen Abad, Laura Calva and Ignacio Luis Campos; counsel and associates of the Labour team; B\u00e1rbara Sainz de Vicu\u00f1a and Diego Iba\u00f1ez; counsel and associate of the IP team; Andrew Ward, partner of the Competition team; Isabel Silva, Joaqu\u00edn Beltr\u00e1n and Patricia Gonz\u00e1lez de Huelbes, associates of the Banking team.<\/p>\n\n\n\n

\n\n Read full article here<\/span>\n
\"icon\"<\/div><\/a>\n <\/div>\n\n\n\n

<\/p>\n\n<\/div>\n<\/div>\n\n\n

\n
\n\n\n
\n\n
\n
\n\n \n
\n
Lawyer mentioned<\/div>\n
\n

\n <\/span>\n David Gonz\u00e1lez<\/a>\n – Socio<\/span>\n <\/p>\n

\n <\/span>\n Diana Linage<\/a>\n – Counsel<\/span>\n <\/p>\n <\/div>\n

\n

\n <\/span>\n Mariana D\u00edaz-Moro<\/a>\n – Socia<\/span>\n <\/p>\n

\n <\/span>\n Irene Ferna\u0301ndez Puyol<\/a>\n – Socia<\/span>\n <\/p>\n

\n <\/span>\n Marta Rey<\/span>\n – Asociada<\/span>\n <\/p>\n

\n <\/span>\n Lourdes Escassi<\/a>\n – Counsel<\/span>\n <\/p>\n

\n <\/span>\n Carmen Abad<\/span>\n – Asociada<\/span>\n <\/p>\n

\n <\/span>\n B\u00e1rbara Sa\u00ednz de Vicun\u0303a<\/a>\n – Counsel<\/span>\n <\/p>\n

\n <\/span>\n Diego Ib\u00e1\u00f1ez<\/span>\n – Asociado<\/span>\n <\/p>\n

\n <\/span>\n Isabel Silva<\/span>\n – Asociada<\/span>\n <\/p>\n

\n <\/span>\n Andrew Ward<\/a>\n – Socio<\/span>\n <\/p>\n

\n <\/span>\n Carla Fandi\u00f1o<\/a>\n – Asociada S\u00e9nior<\/span>\n <\/p>\n <\/div>\n

See all lawyers\"icon\"<\/div>\n
See less lawyers\"icon\"<\/div>\n <\/div>\n \n
\n
Category<\/div>\n

\n <\/span>\n Deal<\/span>\n <\/p>\n <\/div>\n \n

\n
Areas and sectors<\/div>\n

\n <\/span>\n Corporate and M&A<\/a>\n <\/p>\n

\n <\/span>\n Tax<\/a>\n <\/p>\n

\n <\/span>\n Public Law and Regulated Sectors<\/a>\n <\/p>\n

\n <\/span>\n Employment<\/a>\n <\/p>\n

\n <\/span>\n Intellectual Property<\/a>\n <\/p>\n

\n <\/span>\n Banking and Finance<\/a>\n <\/p>\n

\n <\/span>\n Life Sciences and Healthcare<\/a>\n <\/p>\n <\/div>\n <\/div>\n<\/div>\n\n<\/div>\n<\/div>\n\n<\/div>\n\n <\/div>\n\n<\/div>\n\n\n

\n
\n
\n
\n
\n\n
\n\n\n
\n See previous \"icon\"\n <\/a>\n See next \"icon\"\n <\/a>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n\n<\/div>\n\n <\/div>\n\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.<\/p>\n","protected":false},"featured_media":0,"template":"","categoria":[117],"class_list":["post-324801","noticia","type-noticia","status-publish","hentry","categoria-deal-en"],"acf":[],"yoast_head":"\nGA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo<\/title>\n<meta name=\"description\" content=\"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo\" \/>\n<meta property=\"og:description\" content=\"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Despacho de abogados G\u00f3mez-Acebo y Pombo\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-22T17:30:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/news\\\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\\\/\",\"url\":\"https:\\\/\\\/ga-p.com\\\/en\\\/news\\\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\\\/\",\"name\":\"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#website\"},\"datePublished\":\"2024-12-05T12:11:18+00:00\",\"dateModified\":\"2025-01-22T17:30:09+00:00\",\"description\":\"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/news\\\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ga-p.com\\\/en\\\/news\\\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/news\\\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ga-p.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ga-p.com\\\/en\\\/\",\"name\":\"Despacho de abogados G\u00f3mez-Acebo & Pombo\",\"description\":\"G\u00f3mez-Acebo y Pombo es una firma de abogados independiente, con experiencia internacional, especializada en todas las \u00e1reas del derecho de los negocio.\",\"publisher\":{\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ga-p.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#organization\",\"name\":\"Despacho de abogados G\u00f3mez-Acebo & Pombo\",\"url\":\"https:\\\/\\\/ga-p.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ga-p.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo-1-1.svg\",\"contentUrl\":\"https:\\\/\\\/ga-p.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo-1-1.svg\",\"caption\":\"Despacho de abogados G\u00f3mez-Acebo & Pombo\"},\"image\":{\"@id\":\"https:\\\/\\\/ga-p.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo","description":"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/","og_locale":"en_US","og_type":"article","og_title":"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo","og_description":"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.","og_url":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/","og_site_name":"Despacho de abogados G\u00f3mez-Acebo y Pombo","article_modified_time":"2025-01-22T17:30:09+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/","url":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/","name":"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech - Despacho de abogados G\u00f3mez-Acebo y Pombo","isPartOf":{"@id":"https:\/\/ga-p.com\/en\/#website"},"datePublished":"2024-12-05T12:11:18+00:00","dateModified":"2025-01-22T17:30:09+00:00","description":"G\u00f3mez-Acebo & Pombo has advised Ampersand Capital Partners, a private equity firm based in Boston (USA) specialised in the life sciences and healthcare sector, on an investment in the Spanish company Vivebiotech, which develops viral vectors for rare diseases and cancer.","breadcrumb":{"@id":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ga-p.com\/en\/news\/ga_p-advises-ampersand-capital-partners-on-an-investment-in-vivebiotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ga-p.com\/en\/"},{"@type":"ListItem","position":2,"name":"GA_P advises Ampersand Capital Partners on an investment in Vivebiotech"}]},{"@type":"WebSite","@id":"https:\/\/ga-p.com\/en\/#website","url":"https:\/\/ga-p.com\/en\/","name":"Despacho de abogados G\u00f3mez-Acebo & Pombo","description":"G\u00f3mez-Acebo y Pombo es una firma de abogados independiente, con experiencia internacional, especializada en todas las \u00e1reas del derecho de los negocio.","publisher":{"@id":"https:\/\/ga-p.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ga-p.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ga-p.com\/en\/#organization","name":"Despacho de abogados G\u00f3mez-Acebo & Pombo","url":"https:\/\/ga-p.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ga-p.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ga-p.com\/wp-content\/uploads\/2024\/09\/Logo-1-1.svg","contentUrl":"https:\/\/ga-p.com\/wp-content\/uploads\/2024\/09\/Logo-1-1.svg","caption":"Despacho de abogados G\u00f3mez-Acebo & Pombo"},"image":{"@id":"https:\/\/ga-p.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ga-p.com\/en\/wp-json\/wp\/v2\/noticia\/324801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ga-p.com\/en\/wp-json\/wp\/v2\/noticia"}],"about":[{"href":"https:\/\/ga-p.com\/en\/wp-json\/wp\/v2\/types\/noticia"}],"wp:attachment":[{"href":"https:\/\/ga-p.com\/en\/wp-json\/wp\/v2\/media?parent=324801"}],"wp:term":[{"taxonomy":"categoria","embeddable":true,"href":"https:\/\/ga-p.com\/en\/wp-json\/wp\/v2\/categoria?post=324801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}